Danielle Roy/X
Dec 18, 2025, 09:49
Clotting and Bleeding Risks in Cancer: Links to Inflammatory and Cardiac Biomarkers by Danielle Roy et al.
Danielle Roy, Clinical Research Assistant at Health Sciences North Research Institute, shared on X:
“Cancer patients face competing risks of clotting and bleeding. Our new European Heart Journal study shows associations with inflammatory and cardiac biomarkers.”
Title: Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers
Authors: Danielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, Dylan Burger, Marc Carrier, Philip Wells, Steven Hawken.
Find more posts on Hemostasis Today.
-
Apr 8, 2026, 14:42Joshua Muia: The Value of Collaboration and The Importance of Exchanging Ideas Across Institutions
-
Apr 8, 2026, 14:37Gregory Piazza: The Rationale and Methods Behind the New AHA/ACC PE Guidelines Clinical Categories
-
Apr 8, 2026, 14:33Ney Carter Borges: Effectiveness and Safety of Andexanet alfa in Life-Threatening Factor Xa Inhibitor-Associated Bleeding
-
Apr 8, 2026, 14:32IFI Foundation Launches A Youth-Led Stroke Awareness Campaign On World Health Day 2026 – OdishaPlus
-
Apr 8, 2026, 14:24Riccardo Mazza: Do Weight, BMI, and Renal Function Independently Predict Acute Events in NVAF Patients on DOACs?
-
Apr 8, 2026, 14:17Chokri Ben Lamine: Anticoagulation Switching Pearls
-
Apr 8, 2026, 14:13Francisco Chacón-Lozsán: Bleeding on Anticoagulation Is Not a Complication, It’s a Turning Point
-
Apr 8, 2026, 07:32Giulia Simini: Acquired von Willebrand Syndrome and Coagulation Abnormalities in MPN-Associated Thrombocytosis
-
Apr 8, 2026, 07:14Julian Kyoung-Ryul Chun: Join the Discussion at EHRA 2026